Skip to content
Menu

Autolus Therapeutics plc AUTL

Full chart Compare
Set alert

Price alert · AUTL

All alert types
0.91 USD -0.07 (-7.33%)

As ofNov 20, 2026, 2:32 PM EST

0.9075 Day range 0.9797
0.9075 52-week range 2.58
YTD
-54.38%
1 year
-26.20%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Income Tax Benefit$8.65MNet Loss$288.20MCost of Revenue$96.59MExpenses$296.85MGross Loss$21.03MSelling, General & Admin$131.82MResearch & Development$128.59MOther Expenses$15.41MRevenue$75.56MProduct$74.32MLicense$1.07M

Latest period ending Dec 31, 2025 · select a line to chart its full history

AUTL annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
75.39M10.12M1.70M6.36M2.33M
-20.98M-1.27M1.70M6.36M2.33M
-270.03M-241.21M-179.48M-143.41M-141.05M
-287.53M-220.66M-208.38M-148.84M-142.10M
-1.08-0.86-1.20-1.57-1.97
AUTL annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
105.64M228.81M240.34M382.76M310.68M
589.07M782.73M375.38M490.27M405.56M
410.94M355.40M263.91M191.60M92.24M
351.59M300.73M223.87M150.16M68.01M
178.13M427.32M111.47M298.67M313.32M
AUTL annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-283.57M-206.27M-145.59M-112.31M-117.86M
158.46M-394.55M-10.99M-10.84M-8.86M
-4.34M589.55M-883.00K223.61M284.06M
-19.04M-22.07M-10.99M-10.84M-8.86M
-123.17M-11.53M-142.43M72.08M156.59M